Re: VOLUME
in response to
by
posted on
Jun 30, 2021 12:40PM
BKC,,,as is the status quo with this pitiable divestment. Yep,,,its turned into a cartoon. If my post hits a sore point and causes you anguish I appologize,,,that anguish pales in comparison to those investors who just want to get their hard invested monies out at par or close to it. There is a cost to shareholders of a mis-managed public company. And as a shareholder I think we have all earned the right to complain and criticize the continued failures to launch key directives. But wait, mis-information from our uninformed CEO to retail shareholders has been blunt.
This is not just an opinion,,,it bares fact,,,,or havent you noticed?..the saga keeps on, only getting weaker as time passes,,,,,..and supported by the continuation of managements MOA and not knowing the ropes in the biotech business arena. If there is something we are unaware of please provide some hard evidence. The share price IS what matters to investors!!!!!,,no matter what is expected in this company's future endevours. Nothing material has been met yet!
The Market is bidding .84/share for this blockbuster as I type!,,,it looks like it thinks .84 is even too much, based on lot size. Lots of time most likely to get shares cheaper and with warrants over the next couple of years,,,it would not surprise me at all!!!!!